Pages that link to "Q44027697"
Jump to navigation
Jump to search
The following pages link to Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures (Q44027697):
Displaying 50 items.
- The role of oxidative stress in Parkinson's disease (Q24307946) (← links)
- RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells (Q24337982) (← links)
- Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century (Q24630927) (← links)
- Mechanisms of rotenone-induced proteasome inhibition (Q24633912) (← links)
- Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives (Q26747508) (← links)
- Molecular aspects of dopaminergic neurodegeneration: gene-environment interaction in parkin dysfunction (Q26849699) (← links)
- Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease (Q26853610) (← links)
- Protein degradation pathways in Parkinson's disease: curse or blessing (Q27026029) (← links)
- Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease (Q27350440) (← links)
- The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease (Q28254943) (← links)
- p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition (Q28579903) (← links)
- Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein (Q31120123) (← links)
- Role of the ubiquitin proteasome system in Parkinson's disease (Q33307874) (← links)
- Aging is not associated with proteasome impairment in UPS reporter mice (Q33466066) (← links)
- Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease (Q33522039) (← links)
- In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility (Q33582289) (← links)
- Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia (Q33708946) (← links)
- Sirtuin-2 Protects Neural Cells from Oxidative Stress and Is Elevated in Neurodegeneration. (Q33786835) (← links)
- The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors (Q33892755) (← links)
- Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease (Q34085167) (← links)
- The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility (Q34157005) (← links)
- Proteasome inhibitor-induced apoptosis is mediated by positive feedback amplification of PKCdelta proteolytic activation and mitochondrial translocation (Q34214022) (← links)
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution (Q34225700) (← links)
- Neurobiology of alpha-synuclein (Q34332706) (← links)
- Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases (Q34427577) (← links)
- Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases (Q34502221) (← links)
- alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress (Q34522644) (← links)
- The many faces of α-synuclein: from structure and toxicity to therapeutic target (Q34972009) (← links)
- An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. (Q35057159) (← links)
- A recurrent mutation in PARK2 is associated with familial lung cancer (Q35059365) (← links)
- Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies (Q35088093) (← links)
- Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders. (Q35548597) (← links)
- Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses (Q35550995) (← links)
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. (Q35589979) (← links)
- Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies (Q35791524) (← links)
- Linkage between the proteasome pathway and neurodegenerative diseases and aging (Q35913897) (← links)
- Proteolytic dysfunction in neurodegenerative disorders (Q35941669) (← links)
- The centrosome in human genetic disease (Q36058438) (← links)
- Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration. (Q36088792) (← links)
- Treatment of Parkinson's disease : what's on the horizon? (Q36249210) (← links)
- L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease (Q36285084) (← links)
- Protein quality control: the who's who, the where's and therapeutic escapes (Q36432134) (← links)
- Biology of mitochondria in neurodegenerative diseases (Q36488715) (← links)
- Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate (Q36587423) (← links)
- The mammalian centrosome and its functional significance (Q36661673) (← links)
- Autophagy and neurodegeneration: when the cleaning crew goes on strike (Q36760662) (← links)
- Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration (Q36861432) (← links)
- Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies (Q37027500) (← links)
- Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets (Q37137351) (← links)
- Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein (Q37278480) (← links)